Tizona Therapeutics Stock
HealthTechLooking to sell Tizona Therapeutics stock or options?
Tizona Therapeutics is a pioneering immunology company that aims to exploit the capabilities of the immune system for developing effective treatments for cancer and autoimmune diseases. The company's innovative treatments are engineered to regulate the operations of immunosuppressive cells by focusing on the specific cell types and biological processes that cause immune suppression within the tumor microenvironment. This approach allows Tizona Therapeutics to provide patients with comprehensive and long-lasting remission from cancer and autoimmune diseases.
Gilead Sciences, AbbVie Ventures, InterWest Health Partners, Abingworth, InterWest Partners, Amgen Ventures, Canaan Partners, MPM BioImpact, Lightstone Ventures, AbbVie, Johnson & Johnson Innovation - JLABS.